Budget 2025, Jan. 31 -- The Nifty Pharma Index though is down 9%,during year to date in January, with corrections in the markets Nevertheless expectations remain high for the pharma sector as a whole and outlook for Contract drug Research and Manufacturing is looked at with optimism

Leaders as Jonathan Hunt, MD and CEO of Syngene International said that I am going to wait and see what's in the budget, but in general, I think we have seen the the government in India over the recent years pay more attention to our industry, particularly the Pharmaceutical industry with the PLI scheme. They've done quite a lot in recent years and can do more for Contract Research (CDMO business . By tradition, it's been more focused on the manufacturing gen...